| 21st Sep 2020 7:05 am |
RNS |
Lynparza EU recommendation in prostate cancer |
| 21st Sep 2020 7:00 am |
RNS |
Lynparza EU recommendation in ovarian cancer |
| 21st Sep 2020 7:00 am |
RNS |
Tagrisso reduced early lung cancer brain recurrenc |
| 10th Sep 2020 7:01 am |
RNS |
AstraZeneca to list all US securities on Nasdaq |
| 10th Sep 2020 7:00 am |
RNS |
Fasenra PhIII OSTRO trial met co-primary endpoints |
| 1st Sep 2020 3:00 pm |
RNS |
Total Voting Rights |
| 1st Sep 2020 7:00 am |
RNS |
Imfinzi approved in EU for small cell lung cancer |
| 1st Sep 2020 7:00 am |
RNS |
Farxiga reduces CKD progression and risk of death |
| 25th Aug 2020 7:00 am |
RNS |
Ph I trial begins for COVID-19 monoclonal antibody |
| 21st Aug 2020 7:00 am |
RNS |
Imfinzi approved in Japan for SCLC |
| 18th Aug 2020 7:00 am |
RNS |
Imfinzi US Priority Review; four-week, fixed dose |
| 4th Aug 2020 7:00 am |
RNS |
AstraZeneca prices a $3bn bond issue |
| 3rd Aug 2020 3:00 pm |
RNS |
Total Voting Rights |
| 30th Jul 2020 7:25 am |
RNS |
Tagrisso US BTD for EGFRm adjuvant lung cancer |
| 30th Jul 2020 7:18 am |
RNS |
AZN: H1 2020 results |
| 29th Jul 2020 7:00 am |
RNS |
Board Committee Changes |
| 28th Jul 2020 7:00 am |
RNS |
Farxiga DAPA-CKD trial met all endpoints |
| 27th Jul 2020 7:10 am |
RNS |
Calquence receives positive CHMP opinion for CLL |
| 27th Jul 2020 7:05 am |
RNS |
Imfinzi recommended for EU approval in SCLC |
| 27th Jul 2020 7:00 am |
RNS |
AstraZeneca enters collaboration in oncology |
| 24th Jul 2020 7:00 am |
RNS |
Breztri Aerosphere approved in the US for COPD |
| 22nd Jul 2020 3:00 pm |
RNS |
Holding(s) in Company |
| 22nd Jul 2020 3:00 pm |
RNS |
Holding(s) in Company |
| 21st Jul 2020 3:00 pm |
RNS |
Holding(s) in Company |
| 21st Jul 2020 3:00 pm |
RNS |
Holding(s) in Company |
| 20th Jul 2020 2:41 pm |
RNS |
COVID-19 vaccine Phase I/II showed immune response |
| 16th Jul 2020 7:00 am |
RNS |
Director Declaration |
| 9th Jul 2020 7:00 am |
RNS |
Brilinta granted US FDA Priority Review for stroke |
| 8th Jul 2020 7:00 am |
RNS |
Lynparza approved in the EU for pancreatic cancer |
| 1st Jul 2020 3:00 pm |
RNS |
Total Voting Rights |
| 30th Jun 2020 3:00 pm |
RNS |
Director/PDMR Shareholding |
| 30th Jun 2020 7:00 am |
RNS |
Selumetinib granted Japan orphan drug designation |
| 17th Jun 2020 3:03 pm |
RNS |
Holding(s) in Company |
| 17th Jun 2020 3:00 pm |
RNS |
Holding(s) in Company |
| 15th Jun 2020 7:00 am |
RNS |
Agreement to Supply Europe with COVID-19 Vaccine |
| 11th Jun 2020 7:00 am |
RNS |
EMTN Programme Routine Technical Update |
| 1st Jun 2020 3:00 pm |
RNS |
Block listing Interim Review |
| 1st Jun 2020 3:00 pm |
RNS |
Total Voting Rights |
| 1st Jun 2020 7:00 am |
RNS |
Lynparza EU CHMP opinion in pancreatic cancer |
| 1st Jun 2020 7:00 am |
RNS |
Brilinta obtains additional US approval |
